Bicycle Therapeutics PLC reports results for the quarter ended in December - Earnings Summary

Bicycle Therapeutics

28/02/2023 13:02

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of $1.01​​ per share for the quarter ended in December. The
mean expectation of fifteen analysts for the quarter was for a
loss of $1.06 per share.
    * Revenue fell 15.5% to $3.19 million from a year ago;
analysts
expected $3.89 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of $1.01​.
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Bicycle Therapeutics PLC shares had fallen by 21.6% this
quarter.
    * The company reported a quarterly loss of $29.98 million.
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $52.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 01:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.06          -1.01          Beat
 Sep. 30 2022      -0.89          -0.96          Missed
 Jun. 30 2022      -0.85          -0.90          Missed
 Mar. 31 2022      -0.68          -0.93          Missed